Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Part of this new funding will help the Dementias Platform UK team work with the MND community to translate scientific discoveries into real-world treatments.

DPUK logo

Dementias Platform UK, based in Oxford's Department of Psychiatry, welcomes the government’s announcement of £50 million into Motor Neurone Disease (MND) research.

The pledge of £3 million investment by the Medical Research Council towards a translational accelerator,  matched by £3 million from the National Institute for Health and Care Research, will enable the MND community to work in partnership with Dementias Platform UK and the UK Dementia Research Institute.

Professor John Gallacher, Director of DPUK and Professor of Cognitive Health at Oxford University said:

“This is a hugely important boost for MND research. The need for translating discoveries into treatments has never been greater. I am excited at the prospect of DPUK working closely with the MND community to achieve this. We have a growing number of major translational programmes underway, and look forward to extending these to MND.”

The announcement came after a high profile campaign for more funding by Scottish and British & Irish Lions rugby star Doddie Weir who died in November after suffering from MND.



Please follow the link below to read the news on the NIHR BRC website.